3-Pyridyloxypropanolamine agonists of the β3 adrenergic receptor with improved pharmacokinetic properties
作者:Ann E Weber、Hyun O Ok、Raul F Alvaro、Mari R Candelore、Margaret A Cascieri、Shuet-Hing L Chiu、Liping Deng、Michael J Forrest、Gary J Hom、Jennifer E Hutchins、John Kao、D.Euan MacIntyre、Robert J Mathvink、Debra McLoughlin、Randall R Miller、Ronald C Newbold、Timothy V Olah、Emma R Parmee、Leroy Perkins、Ralph A Stearns、Catherine D Strader、John Szumiloski、Yui S Tang、Laurie Tota、Pasquale P Vicario、Matthew J Wyvratt、Michael H Fisher
DOI:10.1016/s0960-894x(98)00381-3
日期:1998.8
Pyridyloxypropanolamines L-749,372 (8, beta(3) EC50 = 3.6 nM) and L-750,355 (29, beta(3) EC50 = 13 nM) are selective partial agonists of the human receptor, with 33% and 49% activation, respectively. Both stimulate lipolysis in rhesus monkeys (ED50 = 2 and 0.8 mg/kg, respectively), with minimal effects on heart rate. Oral bioavailability in dogs, 41% for L-749,372 and 47% for L-750,355, is improved relative to phenol analogs. (C) 1998 Elsevier Science Ltd. All rights reserved.